[EN] TETRACYCLIC HETEROARYL COMPOUNDS<br/>[FR] COMPOSÉS HÉTÉROARYLES TÉTRACYCLIQUES
申请人:ASTRAZENECA AB
公开号:WO2019215203A1
公开(公告)日:2019-11-14
The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
该规范涉及到式(I)的化合物及其药用盐。该规范还涉及用于它们制备的过程和中间体,含有它们的药物组合物以及它们在治疗细胞增殖性疾病中的用途。